Lv2
140 积分 2024-09-30 加入
Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial
1个月前
已完结
Antifibrotic agents in progressive pulmonary fibrosis and non-progressive pulmonary fibrosis of fibrotic hypersensitivity pneumonitis
1个月前
已完结
Effects of immunosuppressants in patients with mild fibrotic hypersensitivity pneumonitis
1个月前
已完结
Management of Fibrotic Hypersensitivity Pneumonitis
1个月前
已完结
Association between Pan-immune-inflammation value and in-hospital mortality in critically ill patients with Chronic obstructive pulmonary disease: An observational study
6个月前
已完结
Corticosteroid therapy for treating acute exacerbation of interstitial lung diseases: a systematic review
7个月前
已完结
Interstitial Lung Abnormalities and the Clinical Course in Patients With COPD
7个月前
已完结
Visual and Quantitative Interstitial Lung Abnormality Progression in COPDGene
7个月前
已完结
Prevalence and progression rate of interstitial lung abnormalities detected on thoracic CT: a systematic review and meta-analysis
7个月前
已完结
Interstitial Lung Abnormality: Narrative Review of the Approach to Diagnosis and Management
7个月前
已完结
皖公网安备34019202002308
